scholarly journals The Results of the Paper by Westhoff et al. “Prospective Evaluation of Antibiotic Management in Ureteral Stent and Nephrostomy Interventions” Should Encourage Proper Use of Antimicrobial Prophylaxis in Patients Undergoing Nephrostomy Tube Replacement

2021 ◽  
pp. 1-2
Author(s):  
Luca Ongaro ◽  
Michele Rizzo ◽  
Carlo Trombetta ◽  
Giovanni Liguori
2014 ◽  
Vol 86 (4) ◽  
pp. 257 ◽  
Author(s):  
Elisa Cicerello ◽  
Franco Merlo ◽  
Mario Mangano ◽  
Giandavide Cova ◽  
Luigi Maccatrozzo

Obiectives: To report our experience of diagnosis and multimodal management of urolithiasis in renal transplantation. Patients and Methods: From January 1995 to December 2012, 953 patients underwent renal transplantation in the Kidney Transplant Unit of Treviso General Hospital. Ten (10%) of them developed urinary calculi and were referred at our institution. Their mode of presentation, investigation and treatment were recorded. Results: Seven had renal and 3 ureteral calculi. Urolithiasis was incidentally discovered on routine ultrasound in 6 patients, 1 presented with oliguria, 1 with anuria and acute renal failure and in 2 urolithiasis was found at removal of the ureteral stent. Nephrostomy tube was placed in 5 patients. Hypercalcemia with hyperparathyroidism (HPT) was present in 5 patients and hyperuricemia in 3. Two patients were primary treated by shock wave lithotripsy (SWL) and one of them was stone-free after two sessions. Two patients, one with multiple pielocaliceal calculi and the other with staghorn calculus in the lower calyx, were treated with percutaneous nephrolitothotomy (PCNL). Three patients were treated by ureteroscopy (URS) and in one of them two treatments were carried out. One patient had calculus impacted in the uretero-vesical anastomosis and surgical ureterolithotomy with re-do ureterocystoneostomy was performed after failure of URS. Two patients with calculi discovered at removal of the ureteral stent were treated by URS. Conclusions: The incidence of urolithiasis in renal transplantation is uncommon. In the most of patients the condition occurs without pain. Metabolic anomalies and medical treatment after renal transplantation may cause stone formation. Advancements in endourology and interventional radiology have influenced the management of urolithiasis that can be actually treated with a minimal incidence of risk for the renal allograft.


2007 ◽  
Vol 33 (3) ◽  
pp. 313-322 ◽  
Author(s):  
Derek Weiland ◽  
Renato N. Pedro ◽  
J. Kyle Anderson ◽  
Sara L. Best ◽  
Lee Courtney ◽  
...  

2009 ◽  
Vol 2009 ◽  
pp. 1-3 ◽  
Author(s):  
Darren Beiko ◽  
Meghana Samant ◽  
Thomas B. McGregor

We report the first case of totally tubeless outpatient percutaneous nephrolithotomy (PCNL). Our patient was discharged home safely less than 4 hours following uncomplicated PCNL with no nephrostomy tube, ureteral stent, or urethral catheter. Follow-up the next day in clinic confirmed that the procedure was successful, as the patient was clinically well and stone free. To our knowledge, this is the first case report of totally tubeless (no nephrostomy, no ureteral stent) PCNL performed on a truly outpatient basis.


2019 ◽  
Vol 201 (Supplement 4) ◽  
Author(s):  
Alberto Olivero* ◽  
Niccolò Ricciardi ◽  
Drilona Ndrevataj ◽  
Federica Balzarini ◽  
Mattia Cerasuolo ◽  
...  

2021 ◽  
Vol 206 (Supplement 3) ◽  
Author(s):  
Rachel Wong ◽  
Sylvain Lother ◽  
Premal Patel ◽  
Barret Rush

2013 ◽  
Vol 189 (4S) ◽  
Author(s):  
Michael Kurtz ◽  
Ronald Arellano ◽  
Avinash Kambadakone ◽  
Deborah Gervais ◽  
Dianne Sacco

2021 ◽  
Vol 1 (S1) ◽  
pp. s29-s29
Author(s):  
Dhatri Kotekal ◽  
Michelle Hecker ◽  
Irma Lengu ◽  
Andrea Son

Background: The American Urologic Association’s 2019 Best Practices Statement highlights the importance of procedural and host factors in optimizing antimicrobial prophylaxis for urologic procedures. For ureteral stent removal, a procedure considered low risk, the recommendation for prophylaxis is uncertain and is dependent primarily on patient factors. We examined periprocedural practices and outcomes for both low-risk and intermediate- to high-risk patients undergoing this procedure in a county hospital. Methods: A retrospective cohort study was performed on all patients who underwent stent removal from January to December 2019. Patients were classified as being low risk if they met the following criteria: age 48 hours within the previous 30 days, absence of external urinary catheters, no intermittent catheterization, absence of prosthetic cardiac valves, not pregnant, and not immunocompromised. All other patients were classified as intermediate to high risk. We assessed periprocedural urine testing, antimicrobial prophylaxis, and clinical outcomes. Results: Of 158 unique patients, 84 (53%) were classified as low risk. As shown in Table 1, preprocedural urine cultures were performed in 55% of low-risk versus 69% of intermediate- to high-risk patients. For the patients for whom urine cultures were performed, cultures were positive in 22% of low-risk versus 55% of intermediate- to high-risk patients (p < .0001). All patients received antimicrobial prophylaxis, most often a single dose after the procedure. None of the low risk patients had a positive urine culture or hospitalization within 30 days post procedure. Conclusions: Overall, 53% of patients undergoing stent removal were considered low-risk hosts, yet 100% of patients received antimicrobial prophylaxis. Future studies are needed to evaluate interventions to reduce unnecessary antimicrobial prophylaxis and standardize preprocedural testing in low-risk patients undergoing stent removal.Funding: NoDisclosures: None


Sign in / Sign up

Export Citation Format

Share Document